ASGN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ASGN is not a strong buy for a beginner, long-term investor at this time. The technical indicators and financial performance do not suggest a compelling entry point, and there are no significant positive catalysts or trading signals to support immediate action.
The MACD histogram is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 62.235, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near resistance levels (R1: 39.586), which may limit short-term upside.
Analysts have raised price targets recently, with some citing improving business conditions and potential AI-driven demand. The acquisition of Quinnox is expected to be accretive to EPS, EBITDA margins, and organic growth.
The company's Q4 2025 financials showed declines in revenue (-0.50% YoY), net income (-40.57% YoY), EPS (-37.23% YoY), and gross margin (-1.48% YoY). Hedge funds and insiders are neutral, with no significant trading trends. No recent news or congress trading data is available.
In Q4 2025, ASGN's financial performance weakened significantly, with declines in revenue, net income, EPS, and gross margin. This indicates a challenging operating environment and raises concerns about the company's growth trajectory.
Analysts have mixed views. BMO Capital and Truist maintain positive ratings with raised price targets, citing improving business conditions and AI-driven demand. However, Wells Fargo lowered its price target, reflecting cautious sentiment.
